A detailed history of Zions Bancorporation, N.A. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 6,013 shares of MEDP stock, worth $1.99 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
6,013
Previous 6,238 3.61%
Holding current value
$1.99 Million
Previous $2.52 Million 1.79%
% of portfolio
0.2%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$372.0 - $424.34 $83,700 - $95,476
-225 Reduced 3.61%
6,013 $2.48 Million
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $73,496 - $106,633
258 Added 4.31%
6,238 $2.52 Million
Q4 2023

Feb 12, 2024

SELL
$227.52 - $312.68 $164,269 - $225,754
-722 Reduced 10.77%
5,980 $1.83 Million
Q3 2023

Nov 07, 2023

BUY
$233.98 - $281.67 $114,416 - $137,736
489 Added 7.87%
6,702 $1.62 Million
Q2 2023

Jul 28, 2023

BUY
$187.26 - $240.17 $8,426 - $10,807
45 Added 0.73%
6,213 $1.49 Million
Q1 2023

May 10, 2023

BUY
$174.31 - $239.52 $112,255 - $154,250
644 Added 11.66%
6,168 $1.16 Million
Q4 2022

Feb 10, 2023

BUY
$153.06 - $226.57 $120,305 - $178,084
786 Added 16.59%
5,524 $1.17 Million
Q3 2022

Nov 08, 2022

SELL
$145.13 - $182.49 $5,950 - $7,482
-41 Reduced 0.86%
4,738 $745,000
Q2 2022

Aug 05, 2022

BUY
$130.2 - $168.03 $609,856 - $787,052
4,684 Added 4930.53%
4,779 $715,000
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $13,192 - $20,359
95 New
95 $16,000
Q2 2019

Jul 09, 2019

SELL
$53.64 - $65.42 $26,122 - $31,859
-487 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$49.38 - $70.58 $8,147 - $11,645
-165 Reduced 25.31%
487 $29,000
Q4 2018

Feb 13, 2019

BUY
$46.97 - $63.98 $30,624 - $41,714
652 New
652 $35,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.